CN1186083C - Chinese medicine for treating mammary gland foliole proliferation - Google Patents
Chinese medicine for treating mammary gland foliole proliferation Download PDFInfo
- Publication number
- CN1186083C CN1186083C CNB031114075A CN03111407A CN1186083C CN 1186083 C CN1186083 C CN 1186083C CN B031114075 A CNB031114075 A CN B031114075A CN 03111407 A CN03111407 A CN 03111407A CN 1186083 C CN1186083 C CN 1186083C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- root
- herba
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating hyperplasia of lobules of mammary glands, which is prepared from angelica, white peony root, bupleurum root, tuckahoe, largehead atractylodes rhizome, cortex moutan root-bark of tree peony, cape jasmine fruit, oyster shell, pinellia tuber, finger citron, paris root, purpleflower crotalarla, pleione rhizome, dandelion, bunge corydalis herb, pumice and radix achyranthis bidentatae, all of which are prepared according to a certain proportion by weight and can be prepared into any common oral dosage form. The traditional Chinese medicine has the effects of dispersing stagnated liver qi for relieving qi stagnation, resolving phlegm, clearing away heat, dissipating binds, activating blood circulation, dissolving stasis and treating malign sores, pyogenic infections, pestilent toxicity, scrofula, acute mastitis, carbuncular sores and ulcers and active chronic inflammation. The traditional Chinese medicine has special effects on treating granular tubercle of breasts, diffuse hardness and thickening of breasts, cystic hyperplasia of mammary glands and active chronic mastitis.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of cyclomastopathy, belong to the field of Chinese medicines.
Background technology
Cyclomastopathy is a kind of non-inflammation shape disease of breast portion, and characteristics are that breast scatters lump, increase the weight of through before swelling and ache, through after alleviate, sickness rate is very high in the women, directly influences women's physical and mental health, also can be described as the early stage omen of canceration.This disease traditional Chinese medical science is called " nodules of the breast " again, and primary disease is many owing to depressed rage impairing the liver, stagnation of QI due to depression of the liver, and worry impairing spleen, dysfunction of the spleen in transportation accumulates in the phlegm-damp, so that liver spleen two wounds, and dysfunction of the spleen in transportation accumulates in the phlegm-damp, so that liver spleen two wounds, stagnation of Qi and phelgm, the stasis of blood stagnates and in bulk.Or because of deficiency of the liver and kindey, due to tying in the Chong and Ren channel disorder, yang deficiency phlegm-damp.The medicine of existing this disease of treatment has: RUPIXIAO, and asparagines etc. take effect slowly but all exist, and the course of treatment is long, the shortcoming that cure rate is low.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition of more effective treatment cyclomastopathy.
Crude drug of the present invention is made up of Radix Angelicae Sinensis, the Radix Paeoniae Alba, Radix Bupleuri, Poria, the Rhizoma Atractylodis Macrocephalae, Cortex Moutan, Fructus Gardeniae, Concha Ostreae, the Rhizoma Pinelliae, Fructus Citri Sarcodactylis, Rhizoma Paridis, Herba Crotalariae sessiliflorae, Pseudobulbus Cremastrae Seu Pleiones, Herba Taraxaci, Herba Violae, Pumex, Radix Achyranthis Bidentatae, make each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat cyclomastopathy.
Wherein Radix Angelicae Sinensis control should menstruction regulating and pain relieving, moisturize laxation, ulcer sores etc.; The Radix Paeoniae Alba is controlled to nourish blood and holds back sun, easing the affected liver to relieve pain etc.; Radix Bupleuri control should deliver and in, yang invigorating resolving depression, feeling of fullness and disecomfort in the chest and hypochondrium etc.; Poria is controlled suitable inducing diuresis to remove edema etc.; The Rhizoma Atractylodis Macrocephalae is controlled and should invigorating middle warmer be good for the stomach etc.; Cortex Moutan is controlled suitable clearing away heat and cooling blood, promoting blood circulation to remove blood stasis, carbuncle etc.; Fructus Gardeniae is controlled suitable pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis etc., and Concha Ostreae is controlled suitable hard masses softening and resolving, metrorrhagia and leukorrhagia scrofula goiter etc.; The Rhizoma Pinelliae is controlled suitable drying dampness to eliminate phlegm, and the thoracic cavity painful abdominal mass is vexed etc.; Fructus Citri Sarcodactylis is controlled suitable activating QI to eliminate phlegm, stagnation of QI carbuncle on the abdominal wall, septum pectorale distension etc.; Rhizoma Paridis is controlled suitable nourishing the lung to loosen bowels, blocked-up chest, the thoracic obstruction, constipation; Herba Crotalariae sessiliflorae controls that should to grow positive kidney tonifying anticancer etc.; Pseudobulbus Cremastrae Seu Pleiones is controlled suitable heat-clearing and toxic substances removing, malignant boil toxic swelling etc.; Herba Taraxaci is controlled suitable heat clearing away eliminating stagnation, acute mastitis etc.; Herba Violae is controlled suitable promoting blood circulation and detumescence, detoxifcation; Pumex is controlled suitable lung heat clearing pathogenic fire reducing, expectorant eliminate indigestion, knob goiter tuberculosis etc.; Radix Achyranthis Bidentatae is controlled suitable blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney etc.
The consumption of drug component of the present invention all has better curative effect in following weight ratio scope:
Radix Angelicae Sinensis 4~8%, the Radix Paeoniae Alba 10~16%, Radix Bupleuri 3~5%, Poria 3~5%, the Rhizoma Atractylodis Macrocephalae 2~4%, Cortex Moutan 3~5%, Fructus Gardeniae 2~4%, Concha Ostreae 15~20%, the Rhizoma Pinelliae 3~5%, Fructus Citri Sarcodactylis 4~8%, Rhizoma Paridis 10~16%, Herba Crotalariae sessiliflorae 3~5%, Pseudobulbus Cremastrae Seu Pleiones 3~5%, Herba Taraxaci 3~5%, Herba Violae 3~5%, Pumex 3~5%, Radix Achyranthis Bidentatae 3~5%.
Be preferably: Radix Angelicae Sinensis 6%, the Radix Paeoniae Alba 11%, Radix Bupleuri 4.5%, Poria 4.5%, the Rhizoma Atractylodis Macrocephalae 3%, Cortex Moutan 4.5%, Fructus Gardeniae 3%, Concha Ostreae 15%, the Rhizoma Pinelliae 4.5%, Fructus Citri Sarcodactylis 6%, Rhizoma Paridis 11%, Herba Crotalariae sessiliflorae 4.5%, Pseudobulbus Cremastrae Seu Pleiones 4.5%, Herba Taraxaci 4.5%, Herba Violae 4.5%, Pumex 4.5%, Radix Achyranthis Bidentatae 4.5%.
The preparation method of medicine of the present invention is: crude drug is ground into the powder mix homogeneously is mixed with powder.
The active component of medicine of the present invention can add various conventional adjuvant required when preparing different dosage form, is prepared into any peroral dosage form commonly used, as tablet, capsule, powder, pill etc.
Medicine of the present invention has dispersing the stagnated live-QI to relieve the stagnation of QI, the reducing phlegm and fever eliminating stagnation, and blood circulation promoting and blood stasis dispelling, the malignant boil toxic swelling, pestilent toxicity is sent out, scrofula tuberculosis, acute mastitis, carbuncle skin infection, effects such as active chronic inflammation; To treatment breast graininess tuberosity, the breast diffusivity is solid to be thickened, cystic hyperplasia of breast, and acute and chronic mastitis has specially good effect.
The specific embodiment
Below further set forth the beneficial effect of medicine of the present invention by clinical observation on the therapeutic effect test.
1, physical data
Accept female patient totally 77 examples for medical treatment, the age is between 25~50 years old.
2, diagnostic criteria
Lump is scattered in the breast, the sheet bulk or the nodositas that do not wait for thickness, or sheet piece, tuberosity, bar rope, sand grains are arranged in the same breast.
3, Therapeutic Method
Oral 3 times of every day, each 5~8 grams, 30 days is a course of treatment.
4, efficacy assessment standard
Cure: sheet bulk, the complete obiteration of nodositas lump; Take a turn for the better: the lump area reduces, but not complete obiteration; Invalid: as not reach improvement standard person.
5, therapeutic outcome
The lighter: lump is the sheet bulk, and half course of treatment cures, and weight person lump is sheet piece and nodositas, and the half improvement course of treatment is cured to one and half courses of treatment for one.
In a word, healing person's 72 examples, 5 examples take a turn for the better.Cure rate is 96%, and total effective rate is 100%.
Claims (2)
1, a kind of Chinese medicine for the treatment of cyclomastopathy, it is characterized in that it is made by the following raw materials by weight percent medicine: Radix Angelicae Sinensis 4~8%, the Radix Paeoniae Alba 10~16%, Radix Bupleuri 3~5%, Poria 3~5%, the Rhizoma Atractylodis Macrocephalae 2~4%, Cortex Moutan 3~5%, Fructus Gardeniae 2~4%, Concha Ostreae 15~20%, the Rhizoma Pinelliae 3~5%, Fructus Citri Sarcodactylis 4~8%, Rhizoma Paridis 10~16%, Herba Crotalariae sessiliflorae 3~5%, Pseudobulbus Cremastrae Seu Pleiones 3~5%, Herba Taraxaci 3~5%, Herba Violae 3~5%, Pumex 3~5%, Radix Achyranthis Bidentatae 3~5%, pulverize promptly is mixed with.
2, a kind of Chinese medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: the percentage by weight of each crude drug is: Radix Angelicae Sinensis 6%, the Radix Paeoniae Alba 11%, Radix Bupleuri 4.5%, Poria 4.5%, the Rhizoma Atractylodis Macrocephalae 3%, Cortex Moutan 4.5%, Fructus Gardeniae 3%, Concha Ostreae 15%, the Rhizoma Pinelliae 4.5%, Fructus Citri Sarcodactylis 6%, Rhizoma Paridis 11%, Herba Crotalariae sessiliflorae 4.5%, Pseudobulbus Cremastrae Seu Pleiones 4.5%, Herba Taraxaci 4.5%, Herba Violae 4.5%, Pumex 4.5%, Radix Achyranthis Bidentatae 4.5%, pulverize promptly is mixed with.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031114075A CN1186083C (en) | 2003-04-07 | 2003-04-07 | Chinese medicine for treating mammary gland foliole proliferation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031114075A CN1186083C (en) | 2003-04-07 | 2003-04-07 | Chinese medicine for treating mammary gland foliole proliferation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1442175A CN1442175A (en) | 2003-09-17 |
CN1186083C true CN1186083C (en) | 2005-01-26 |
Family
ID=27796879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031114075A Expired - Fee Related CN1186083C (en) | 2003-04-07 | 2003-04-07 | Chinese medicine for treating mammary gland foliole proliferation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1186083C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101342357B (en) * | 2008-09-08 | 2010-12-29 | 杜彦秋 | Chinese medicinal composition for treating gland hyperplasia and preventing and controlling mammary cancer |
CN101485756B (en) * | 2009-02-19 | 2011-06-15 | 中国人民解放军第四军医大学 | Chinese medicament preparation for treating mammary gland fibroid tumor and preparation method thereof |
CN102258603B (en) * | 2010-05-28 | 2013-06-26 | 上海中医药大学附属曙光医院 | Medicinal preparation for treating plasma cell mastitis and preparation method thereof |
CN103446536B (en) * | 2013-08-28 | 2015-08-05 | 贵州鸿德中药开发有限公司 | A kind of Miao Ethnomedicine for the treatment of cyclomastopathy |
-
2003
- 2003-04-07 CN CNB031114075A patent/CN1186083C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1442175A (en) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1375298A (en) | Pain-relieving notoginseng mixture | |
CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
CN101874867A (en) | Chinese medicinal preparation for treating psoriasis | |
CN101062357A (en) | Medicine for treating peptic ulcer and chronic gastritis | |
CN1265833C (en) | Chinese medicinal preparation for treating cancer | |
CN1457834A (en) | Detoxicating pill | |
CN101897882B (en) | Medicament for treating and breast lobular hyperplasia and cyst | |
CN1317021C (en) | Chinese medicinal formulation for stopping pain for removing Bi | |
CN100352465C (en) | Medicinal liquor for treating rheumatic arthrolithiasis and its preparing method | |
CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
CN1186083C (en) | Chinese medicine for treating mammary gland foliole proliferation | |
CN101214365B (en) | Chinese medicine composing prescription for treating mastoproliferation | |
CN101199798A (en) | Pressurized spray for treating rheumatism ache | |
CN100381155C (en) | Medicine for treating mammary glands hyperplasia | |
CN1186065C (en) | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation | |
CN1958046A (en) | Wine for promoting blood circulation and activating the channels | |
CN1045893C (en) | Chinese herb medicines formula for treating hysteromyoma with hedyotis diffusa, etc. | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN104288597A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
CN1278706C (en) | Medicine for treating wind-dampness syndrome | |
CN1314409C (en) | Medicine for inhibiting and eliminating cancer | |
CN103638474B (en) | A kind of Chinese medicine for the treatment of atrophic gastritis | |
CN102198215A (en) | Traditional Chinese medicine used for treating mammitis | |
CN101810745B (en) | Plaster for treating hyperplasia of mammary glands | |
CN105664058A (en) | Traditional Chinese medicinal composition for treating functional abdominal distension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |